Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04503993 · ClinicalTrials.gov registry record · NA
Healthy Planet Hepatitis B
A NA study of Hepatitis B, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 5,004
- Enrollment target
- 1
- Study location
NCT04503993 is a NA study of Hepatitis B that has completed, run by University of California, Davis. The registered enrollment target is 5,004 participants, above the 1,472-participant average among 32 other Hepatitis B trials with a reported enrollment target (240% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04503993, a NA study of Hepatitis B, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,004 participants
- Enrollment target
- 1
- Study location
Study Summary
This quality improvement project utilizes Epic Health Planet to increase screening for chronic hepatitis B through the creation of registries and ordering of hepatitis B laboratory panels.
Conditions Studied
Interventions
- OTHER Hepatitis B surface antigen, Hepatitis B core antibody, and Hepatitis B surface antibody
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,004 participants |
| Start Date | 2020-02-25 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04503993
The ClinicalTrials.gov registry entry for NCT04503993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,004 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,472-participant average among 32 other Hepatitis B trials with a reported enrollment target (240% higher). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hepatitis B appearing as the primary indexed condition, and to 1 intervention - of which Hepatitis B surface antigen, Hepatitis B core antibody, and Hepatitis B surface antibody is the first listed.
NCT04503993 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04503993 about?
NCT04503993 is a clinical study titled "Healthy Planet Hepatitis B". This quality improvement project utilizes Epic Health Planet to increase screening for chronic hepatitis B through the creation of registries and ordering of hepatitis B laboratory panels.
What is the current status of trial NCT04503993?
This trial is currently completed. It is a NA study. The enrollment target is 5,004 participants. The study started on 2020-02-25. Estimated completion is 2021-12-31.
What conditions does trial NCT04503993 study?
This clinical trial studies the following conditions: Hepatitis B.
What interventions are being tested in trial NCT04503993?
The interventions under investigation include: Hepatitis B surface antigen, Hepatitis B core antibody, and Hepatitis B surface antibody (OTHER).
Who is sponsoring clinical trial NCT04503993?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04503993 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis B
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
COMPLETED · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
RECRUITING · Phase 4
-
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
RECRUITING · Phase 2
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.